afelimomab(156227-98-4)
- Name: afelimomab
- Synonyms:Afelimomab;Immunoglobulin G 3 (mouse monoclonal LU54107 F(ab')2 fragment g-chain anti-human tumor necrosisfactor a), disulfide with mousemonoclonal LU54107 k-chain, dimer; Segard
- Molecular Formula:
- Molecular Weight:0.00000
- CAS Registry Number:156227-98-4
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 54175-83-6/13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido[3',2':14,15][1,11]dioxacycloeicosino[2,3,4-ij]isoquinolinium, 2,3,13a,14,15,16,25,25a-octahydro-9,19-dihydroxy-18,29-dimethoxy-1,1,14-trimethyl-, (13aR,25aS)- (9CI)
- 55493-89-5/N-(2-Hydroxybenzoyl)glycine methyl ester
- 72462-86-3/2-methyl-2-[(2,3,5,6-tetramethylphenyl)sulfanyl]propanoic acid
- 63075-76-3/2-phenyl-1,2-azaphosphinane 2-oxide
- 6628-93-9/4-(phenylamino)quinolin-2(1H)-one
- 86625-99-2/2-[(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethanol
- 85566-28-5/Fatty acids, coco, mixed esters with heptanoic acid and trimethylolpropane
- 3144-47-6/7-hydroxy-6H-benzo[7]annulen-6-one
- 68309-59-1/Trimethylolpropane, glycerol, acrylic acid, rosin polymer
- 16130-76-0/calcium terephthalate
- 173324-76-0/Benzenesulfonamide,4-chloro-N-(5-nitro-2- thiazolyl)-
- 180615-37-6/Vanadium, (C,C,C,C,C,C,C,C-octafluoro-N,N',N'',N''',N'''',N''''',N'''''',N'''''''-octaphenyl-29H,31H-phthalocyanine-C,C,C,C,C,C,C,C-octaminato(2-)-kappaN29,kappaN30,kappaN31,kappaN32)oxo-
- 13639-69-5/diethyl(propyl)phosphane sulfide
- 36540-22-4/[trisulfane-1,3-diylbis(methanediylbenzene-2,1-diyl)]dimethanesulfinic acid
- 31074-60-9/2-Propenoic acid, 2-methyl-, oxiranylmethyl ester, polymer with 2-ethylhexyl 2-propenoate, methyl 2-propenoate and 2-propenoic acid
- 183854-97-9/(4a.alpha.,5.alpha.,6.beta.,7.beta.)-3,3-[Tetrahydro-5,6-dihydroxy-2-oxo-4,7-bis(phenylmethy)-1H-1,3-diazepine-1,3(2H)-diyl]bis(methylene)bis[N-(6-methyl-2-pyridinyl)benzamide]
- 77791-23-2/2-diethylamino-N-methyl-N-[2-(3-methylphenoxy)ethyl]acetamide hydrochl oride
- 24147-54-4/cholest-5-en-3-yl 4-(aziridin-1-yl)-3,5-dinitrobenzoate
- 71410-74-7/Naphthylazoxine
- 156227-98-4/afelimomab
- 17235-02-8/10,10'-Spirobi[10H-phenoxastannin](9CI)
- 6976-00-7/7-ethyl-2-methylundecan-4-one
- 3415-60-9/(phenylimino)dipropane-3,1-diyl dimethanesulfonate hydrochloride (1:1)
- 80568-19-0/1-{[2-(diethylamino)ethyl]amino}-2-hydroxy-4-methyl-9H-thioxanthen-9-one
- 19393-68-1/1-hydroperoxyethanol
- 32126-82-2/Poly[imino-1,2-ethanediylimino(1,10-dioxo-1,10-decanediyl)]
- 76681-25-9/2-Hydroxy-N-(2-phenoxyphenyl)benzamide
- 123361-54-6/2-Propenoic acid,3-(4-methoxyphenyl)-,2- ethylhexyl ester,mixt. with 4-methoxy-7H-furo[3,2-g][1]benzopyran-7- one
- 1868-53-7/Dibromofluoromethane
- 91994-98-8/Amides, C18-22, N-(2-((2-aminoethyl)amino)ethyl), reaction products with urea